Akoya and Johns Hopkins’ Collaborative Agreement Supports Pioneering New Approach to Immunotherapy Biomarker Discovery and Validation

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Akoya and Johns Hopkins collaborate to develop, validate, and clinically implement novel spatial phenotypic signatures.